UA116755C2 - PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained - Google Patents

PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained

Info

Publication number
UA116755C2
UA116755C2 UAA201709793A UAA201709793A UA116755C2 UA 116755 C2 UA116755 C2 UA 116755C2 UA A201709793 A UAA201709793 A UA A201709793A UA A201709793 A UAA201709793 A UA A201709793A UA 116755 C2 UA116755 C2 UA 116755C2
Authority
UA
Ukraine
Prior art keywords
immunostained
suppositories
erosion
inflammatory
pharmaceutical composition
Prior art date
Application number
UAA201709793A
Other languages
Ukrainian (uk)
Inventor
Іван Антонович Мазур
Людмила Іванівна Кучеренко
Ігор Федорович Бєленічев
Original Assignee
Товариство З Обмеженою Відповідальністю "Науково-Виробниче Об'Єднання "Фарматрон"
Товариство З Обмеженою Відповідальністю "Мобіль Медікал"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товариство З Обмеженою Відповідальністю "Науково-Виробниче Об'Єднання "Фарматрон", Товариство З Обмеженою Відповідальністю "Мобіль Медікал" filed Critical Товариство З Обмеженою Відповідальністю "Науково-Виробниче Об'Єднання "Фарматрон"
Priority to UAA201709793A priority Critical patent/UA116755C2/en
Publication of UA116755C2 publication Critical patent/UA116755C2/en
Priority to EA201891953A priority patent/EA034431B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід належить до галузі медицини та стосується фармацевтичної композиції у формі супозиторіїв з ранозагоюючою, антиерозійною, протизапальною, антимікробною, протигрибковою, імуномодулюючою та антиоксидантною дією, що містить активні речовини тіотриазолін та декаметоксин та основу, при цьому співвідношення активних речовин є наступним: декаметоксин в межах від 0,5 до 5,0 масових часток на 100 масових часток тіотриазоліну.The invention relates to medicine and relates to a pharmaceutical composition in the form of suppositories with wound healing, anti-erosion, anti-inflammatory, antimicrobial, antifungal, immunomodulatory and antioxidant action, containing the active substances thiotriazolin and decavimoxin 0.5 to 5.0 parts by weight per 100 parts by weight of thiotriazoline.

UAA201709793A 2017-10-09 2017-10-09 PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained UA116755C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UAA201709793A UA116755C2 (en) 2017-10-09 2017-10-09 PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained
EA201891953A EA034431B1 (en) 2017-10-09 2018-09-28 Pharmaceutical composition in the form of suppository with wound-healing, anti-erosive, anti-inflammatory, antimicrobial, antifungal, immunomodulating and antioxidant action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201709793A UA116755C2 (en) 2017-10-09 2017-10-09 PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained

Publications (1)

Publication Number Publication Date
UA116755C2 true UA116755C2 (en) 2018-04-25

Family

ID=62027344

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201709793A UA116755C2 (en) 2017-10-09 2017-10-09 PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained

Country Status (2)

Country Link
EA (1) EA034431B1 (en)
UA (1) UA116755C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2755480C1 (en) * 2020-12-10 2021-09-16 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Eye drops

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27543C2 (en) * 1995-09-14 2000-09-15 Georgij Andreevich Golik A biologically active preparation containing vinylene ethonium and decamethoxin
RU2216326C2 (en) * 2001-04-12 2003-11-20 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Wound-healing suppository
RU2317818C2 (en) * 2005-04-07 2008-02-27 Общество с ограниченной ответственностью "Научно-производственое объединение "Фарматрон" (НПО "Фарматрон") Wound-healing and antibacterial agent
UA105127C2 (en) * 2013-04-17 2014-04-10 Олександр Петрович Пенчук Pharmaceutical composition in form of ointment possessing anti-inflammatory, antibacterial and reparation activities
WO2015183230A1 (en) * 2014-05-30 2015-12-03 Наталия Мыколаивна ДЕРКАЧ Composition based on a stabilized solution of active ingredients

Also Published As

Publication number Publication date
EA034431B1 (en) 2020-02-07
EA201891953A2 (en) 2019-04-30
EA201891953A3 (en) 2019-05-31

Similar Documents

Publication Publication Date Title
NI201700011A (en) 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES.
BR112016026291A2 (en) BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
UY36944A (en) COMPOSITIONS OF NOVEDOUS FUNGICIDE BLENDS THAT INCLUDE PYRIDINYLAMIDINS
CO2017011411A2 (en) Derivatives of amido substituted cyclohexane
TR201910397T4 (en) Herbicidal composition containing cinmethylin and imazamox.
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
EA201892822A1 (en) NEW ANTIBACTERIAL CONNECTIONS
ECSP18060875A (en) DERIVATIVES OF 8-AMINO-2-OXO-1,3-DIAZA-SPIRO- [4.5] -DECANO
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
CL2019002480A1 (en) Pyrazole derivatives as bromodomain inhibitors.
UA113151C2 (en) APPLICATION OF ANTI-MICROBIAL POLYPEPTIDE COMPOSITION IN THE PRODUCTION OF MEDICINAL PRODUCT
MX2017006476A (en) Combination therapy effective against microorganisms, including drug resistant microorganisms.
UA116755C2 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF suppositories with early healing, anti-erosion, anti-inflammatory, anti-microbial, anti-fungal, immunostained and immunostained
MA39955A (en) Disinfectant and antimicrobial compositions, in particular for the veterinary field
BR112018016715A2 (en) oritavancin formulations?
WO2014205127A3 (en) Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targets
CY1122979T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNGIASIS
PE20240087A1 (en) COMPOSITION FOR THE CONTROL OF DISEASES IN PLANTS
BR112017024126B8 (en) PHARMACEUTICAL COMPOSITIONS, MICRONIZED COMPOUND A AND/OR AT LEAST ONE MICRONIZED PHARMACEUTICALLY ACCEPTABLE SALT OF COMPOUND A AND USE THEREOF
EA201692493A1 (en) ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS WITH THE ABILITY TO INHIBIT MULTIPLE DOSE SUSTAINABILITY
ECSP21027009A (en) DERIVATIVES OF 4-PIRAZIN-2-ILMETIL-MORPHOLINA AND THEIR USE AS A MEDICINAL PRODUCT
AR099596A1 (en) COMBINATIONS OF ACTIVE COMPOUNDS THAT HAVE INSECTICIATED PROPERTIES
WO2019179953A3 (en) Antimicrobial compositions